Citation 125740

OKUBO,K: KUDOU,S: UCHIDA,T: YOSHIKI,Y: YOSHIKOSHI,M: TONOMURA,M:. (1994). SOYBEAN SAPONIN AND ISOFLAVONOIDS: STRUCTURE AND ANTIVIRAL ACTIVITY AGAINST HUMAN IMMUNODEFICIENCY VIRUS IN VITRO.. 546()

Citation Details

Title	SOYBEAN SAPONIN AND ISOFLAVONOIDS: STRUCTURE AND ANTIVIRAL ACTIVITY AGAINST HUMAN IMMUNODEFICIENCY VIRUS IN VITRO.
Authors	OKUBO,K: KUDOU,S: UCHIDA,T: YOSHIKI,Y: YOSHIKOSHI,M: TONOMURA,M:
Year	1994
Volume	546
Issue

Summary

Year: 1994

Journal: Unknown

Organisms and Their Experiments (1)

Glycine max (FABACEAE)

Experiment #	Pharmacology Type	Worktypes	Compound	Results
1	Not specified	ISOLATION AND IDENTIFICATION OF	DAIDZIN,6''-O-MALONYL:	None
2	TYROSINE PROTEIN KINASE INHIBITION	PHARMACOLOGY OF COMPOUND - IN VITRO	DAIDZIN,6''-O-MALONYL:	ACTIVE
3	KINASE ACTIVITY INHIBITION	PHARMACOLOGY OF COMPOUND - IN VITRO	DAIDZIN,6''-O-MALONYL:	ACTIVE
4	CARCINOGENESIS INHIBITION	PHARMACOLOGY OF COMPOUND - IN VIVO	DAIDZIN,6''-O-MALONYL:	ACTIVE
5	ESTROGENIC EFFECT	PHARMACOLOGY OF COMPOUND - IN HUMANSANTIFERTILITY	DAIDZIN,6''-O-MALONYL:	ACTIVE
6	IMMUNOSTIMULANT ACTIVITY	PHARMACOLOGY OF COMPOUND - IN VIVO	DAIDZIN,6''-O-MALONYL:	ACTIVE
7	CYTOTOXIC ACTIVITY	PHARMACOLOGY OF COMPOUND - IN VITROANTICANCER AND/OR CYTOTOXICITY MARKER CODE	DAIDZIN,6''-O-MALONYL:	ACTIVE
8	CYTOTOXIC ACTIVITY	PHARMACOLOGY OF COMPOUND - IN VITROANTICANCER AND/OR CYTOTOXICITY MARKER CODE	DAIDZIN,6''-O-MALONYL:	ACTIVE
9	CYTOTOXIC ACTIVITY	PHARMACOLOGY OF COMPOUND - IN VITROANTICANCER AND/OR CYTOTOXICITY MARKER CODE	DAIDZIN,6''-O-MALONYL:	ACTIVE
10	PHORBOL ESTER ANTAGONIST	PHARMACOLOGY OF COMPOUND - IN VITRO	DAIDZIN,6''-O-MALONYL:	ACTIVE
11	ANTIVIRAL ACTIVITY	PHARMACOLOGY OF COMPOUND - IN VITROANTIBIOTIC MARKER CODE. (USE WITH 14XXX MPASPA)	DAIDZIN,6''-O-MALONYL:	ACTIVE
12	SYNCYTIA INHIBITION	PHARMACOLOGY OF COMPOUND - IN VITRO	DAIDZIN,6''-O-MALONYL:	ACTIVE
13	Not specified	ISOLATION AND IDENTIFICATION OF	GLYCITIN,6''-O-MALONYL:	None
14	TYROSINE PROTEIN KINASE INHIBITION	PHARMACOLOGY OF COMPOUND - IN VITRO	GLYCITIN,6''-O-MALONYL:	ACTIVE
15	KINASE ACTIVITY INHIBITION	PHARMACOLOGY OF COMPOUND - IN VITRO	GLYCITIN,6''-O-MALONYL:	ACTIVE
16	CARCINOGENESIS INHIBITION	PHARMACOLOGY OF COMPOUND - IN VIVO	GLYCITIN,6''-O-MALONYL:	ACTIVE
17	ESTROGENIC EFFECT	PHARMACOLOGY OF COMPOUND - IN HUMANSANTIFERTILITY	GLYCITIN,6''-O-MALONYL:	ACTIVE
18	IMMUNOSTIMULANT ACTIVITY	PHARMACOLOGY OF COMPOUND - IN VIVO	GLYCITIN,6''-O-MALONYL:	ACTIVE
19	CYTOTOXIC ACTIVITY	PHARMACOLOGY OF COMPOUND - IN VITROANTICANCER AND/OR CYTOTOXICITY MARKER CODE	GLYCITIN,6''-O-MALONYL:	ACTIVE
20	CYTOTOXIC ACTIVITY	PHARMACOLOGY OF COMPOUND - IN VITROANTICANCER AND/OR CYTOTOXICITY MARKER CODE	GLYCITIN,6''-O-MALONYL:	ACTIVE
21	CYTOTOXIC ACTIVITY	PHARMACOLOGY OF COMPOUND - IN VITROANTICANCER AND/OR CYTOTOXICITY MARKER CODE	GLYCITIN,6''-O-MALONYL:	ACTIVE
22	PHORBOL ESTER ANTAGONIST	PHARMACOLOGY OF COMPOUND - IN VITRO	GLYCITIN,6''-O-MALONYL:	ACTIVE
23	ANTIVIRAL ACTIVITY	PHARMACOLOGY OF COMPOUND - IN VITROANTIBIOTIC MARKER CODE. (USE WITH 14XXX MPASPA)	GLYCITIN,6''-O-MALONYL:	ACTIVE
24	SYNCYTIA INHIBITION	PHARMACOLOGY OF COMPOUND - IN VITRO	GLYCITIN,6''-O-MALONYL:	ACTIVE
25	Not specified	ISOLATION AND IDENTIFICATION OF	GENISTIN,6''-O-MALONYL:	None
26	TYROSINE PROTEIN KINASE INHIBITION	PHARMACOLOGY OF COMPOUND - IN VITRO	GENISTIN,6''-O-MALONYL:	ACTIVE
27	KINASE ACTIVITY INHIBITION	PHARMACOLOGY OF COMPOUND - IN VITRO	GENISTIN,6''-O-MALONYL:	ACTIVE
28	CARCINOGENESIS INHIBITION	PHARMACOLOGY OF COMPOUND - IN VIVO	GENISTIN,6''-O-MALONYL:	ACTIVE
29	ESTROGENIC EFFECT	PHARMACOLOGY OF COMPOUND - IN HUMANSANTIFERTILITY	GENISTIN,6''-O-MALONYL:	ACTIVE
30	IMMUNOSTIMULANT ACTIVITY	PHARMACOLOGY OF COMPOUND - IN VIVO	GENISTIN,6''-O-MALONYL:	ACTIVE
31	CYTOTOXIC ACTIVITY	PHARMACOLOGY OF COMPOUND - IN VITROANTICANCER AND/OR CYTOTOXICITY MARKER CODE	GENISTIN,6''-O-MALONYL:	ACTIVE
32	CYTOTOXIC ACTIVITY	PHARMACOLOGY OF COMPOUND - IN VITROANTICANCER AND/OR CYTOTOXICITY MARKER CODE	GENISTIN,6''-O-MALONYL:	ACTIVE
33	CYTOTOXIC ACTIVITY	PHARMACOLOGY OF COMPOUND - IN VITROANTICANCER AND/OR CYTOTOXICITY MARKER CODE	GENISTIN,6''-O-MALONYL:	ACTIVE
34	PHORBOL ESTER ANTAGONIST	PHARMACOLOGY OF COMPOUND - IN VITRO	GENISTIN,6''-O-MALONYL:	ACTIVE
35	ANTIVIRAL ACTIVITY	PHARMACOLOGY OF COMPOUND - IN VITROANTIBIOTIC MARKER CODE. (USE WITH 14XXX MPASPA)	GENISTIN,6''-O-MALONYL:	ACTIVE
36	SYNCYTIA INHIBITION	PHARMACOLOGY OF COMPOUND - IN VITRO	GENISTIN,6''-O-MALONYL:	ACTIVE
37	Not specified	ISOLATION AND IDENTIFICATION OF	SOYASAPONIN B-B	None
38	TYROSINE PROTEIN KINASE INHIBITION	PHARMACOLOGY OF COMPOUND - IN VITRO	SOYASAPONIN B-B	ACTIVE
39	KINASE ACTIVITY INHIBITION	PHARMACOLOGY OF COMPOUND - IN VITRO	SOYASAPONIN B-B	ACTIVE
40	CARCINOGENESIS INHIBITION	PHARMACOLOGY OF COMPOUND - IN VIVO	SOYASAPONIN B-B	ACTIVE
41	ESTROGENIC EFFECT	PHARMACOLOGY OF COMPOUND - IN HUMANSANTIFERTILITY	SOYASAPONIN B-B	ACTIVE
42	IMMUNOSTIMULANT ACTIVITY	PHARMACOLOGY OF COMPOUND - IN VIVO	SOYASAPONIN B-B	ACTIVE
43	CYTOTOXIC ACTIVITY	PHARMACOLOGY OF COMPOUND - IN VITROANTICANCER AND/OR CYTOTOXICITY MARKER CODE	SOYASAPONIN B-B	ACTIVE
44	CYTOTOXIC ACTIVITY	PHARMACOLOGY OF COMPOUND - IN VITROANTICANCER AND/OR CYTOTOXICITY MARKER CODE	SOYASAPONIN B-B	ACTIVE
45	CYTOTOXIC ACTIVITY	PHARMACOLOGY OF COMPOUND - IN VITROANTICANCER AND/OR CYTOTOXICITY MARKER CODE	SOYASAPONIN B-B	ACTIVE
46	PHORBOL ESTER ANTAGONIST	PHARMACOLOGY OF COMPOUND - IN VITRO	SOYASAPONIN B-B	ACTIVE
47	ANTIVIRAL ACTIVITY	PHARMACOLOGY OF COMPOUND - IN VITROANTIBIOTIC MARKER CODE. (USE WITH 14XXX MPASPA)	SOYASAPONIN B-B	ACTIVE
48	SYNCYTIA INHIBITION	PHARMACOLOGY OF COMPOUND - IN VITRO	SOYASAPONIN B-B	ACTIVE
49	Not specified	ISOLATION AND IDENTIFICATION OF	SOYASAPONIN B-1	None
50	TYROSINE PROTEIN KINASE INHIBITION	PHARMACOLOGY OF COMPOUND - IN VITRO	SOYASAPONIN B-1	ACTIVE
51	KINASE ACTIVITY INHIBITION	PHARMACOLOGY OF COMPOUND - IN VITRO	SOYASAPONIN B-1	ACTIVE
52	CARCINOGENESIS INHIBITION	PHARMACOLOGY OF COMPOUND - IN VIVO	SOYASAPONIN B-1	ACTIVE
53	ESTROGENIC EFFECT	PHARMACOLOGY OF COMPOUND - IN HUMANSANTIFERTILITY	SOYASAPONIN B-1	ACTIVE
54	IMMUNOSTIMULANT ACTIVITY	PHARMACOLOGY OF COMPOUND - IN VIVO	SOYASAPONIN B-1	ACTIVE
55	CYTOTOXIC ACTIVITY	PHARMACOLOGY OF COMPOUND - IN VITROANTICANCER AND/OR CYTOTOXICITY MARKER CODE	SOYASAPONIN B-1	ACTIVE
56	CYTOTOXIC ACTIVITY	PHARMACOLOGY OF COMPOUND - IN VITROANTICANCER AND/OR CYTOTOXICITY MARKER CODE	SOYASAPONIN B-1	ACTIVE
57	CYTOTOXIC ACTIVITY	PHARMACOLOGY OF COMPOUND - IN VITROANTICANCER AND/OR CYTOTOXICITY MARKER CODE	SOYASAPONIN B-1	ACTIVE
58	PHORBOL ESTER ANTAGONIST	PHARMACOLOGY OF COMPOUND - IN VITRO	SOYASAPONIN B-1	ACTIVE
59	ANTIVIRAL ACTIVITY	PHARMACOLOGY OF COMPOUND - IN VITROANTIBIOTIC MARKER CODE. (USE WITH 14XXX MPASPA)	SOYASAPONIN B-1	ACTIVE
60	SYNCYTIA INHIBITION	PHARMACOLOGY OF COMPOUND - IN VITRO	SOYASAPONIN B-1	ACTIVE

Citation 125740

Citation Details

Summary

Organisms and Their Experiments (1)

Glycine max (FABACEAE)

Show SPARQL Queries (1)

Query 1